Informations générales (source: ClinicalTrials.gov)
Long-term Sequelae of Childhood Meningitis and Meningococcal Purpura Fulminans in Ile de France: a Multidisciplinary Approach
Observational
Centre Hospitalier Intercommunal Creteil (Voir sur ClinicalTrials)
juillet 2021
mai 2025
13 mai 2026
While the initial evolution of meningococcal meningitis (MM) is well described, there are
few data on the long-term evolution, beyond 1 year.
The objective of this research is to evaluate the sequelae of MM beyond 1 year in
patients with a history of MM followed in Paris area, France. Most children with MM in
France have been included in the MM register and are still being followed. Parents will
be offered a detailed clinical evaluation of their child including: a clinical and
neurological examination, a cognitive performance assessment, an auditory, speech and
visual assessment and an evaluation of the child's progress at school.
Etablissements
Critères
Tous
- Infants and children from 0 to 17 years old
- Having had meningitis or meningococcal purpura fulminans between 2010 and 2021
- Delay ≥ 1 year between the date of diagnosis of meningitis or purpura meningococcal
fulminans and the date of inclusion in the study (signature of the informed consent)
- The holders of parental authority have read and understood the information letter
and their express consent has been obtained
- Patient affiliated to a social security system (Social Security or Universal Medical
Coverage)
Exclusion Criteria:
- refusal to participate